Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients

Unknown 80 enrolled Shahid Beheshti University of Medical Sciences

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine whether bevacizumab 1-2 weeks before vitrectomy is effective in lowering the rate of early post-vitrectomy vitreous hemorrhage in diabetic patients.

Timeline

Start: 2007-01
Primary completion: —
Completion: 2007-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bevacizumab	Monoclonal antibody	1.25 mg	Intravitreal

Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients

Summary

Timeline

Drugs

Indications